News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
110,909 Results
Type
Article (4293)
Company Profile (20)
Press Release (106596)
Multimedia
Podcasts (1)
Webinars (2)
Section
Business (31987)
Career Advice (110)
Deals (5254)
Drug Delivery (5)
Drug Development (5418)
Employer Resources (11)
FDA (3204)
Job Trends (2079)
News (46989)
Policy (3876)
Tag
Academia (367)
Accelerated approval (2)
Allergies (10)
Alliances (11212)
ALS (14)
Alzheimer's disease (381)
Antibody-drug conjugate (ADC) (11)
Approvals (3267)
Artificial intelligence (163)
Autoimmune disease (11)
Automation (11)
Bankruptcy (45)
Best Places to Work (1718)
BIOSECURE Act (1)
Biosimilars (11)
Biotechnology (11)
Bladder cancer (23)
Brain cancer (7)
Breast cancer (143)
Cancer (879)
Cardiovascular disease (53)
Career advice (101)
Career pathing (2)
CAR-T (16)
CDC (1)
Celiac Disease (1)
Cell therapy (41)
Cervical cancer (10)
Clinical research (4414)
Collaboration (353)
Compensation (26)
Complete response letters (3)
COVID-19 (487)
CRISPR (6)
C-suite (106)
Cystic fibrosis (14)
Data (655)
Decentralized trials (1)
Depression (15)
Diabetes (32)
Diagnostics (6124)
Digital health (19)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (27)
Drug pricing (4)
Drug shortages (2)
Duchenne muscular dystrophy (6)
Earnings (10924)
Editorial (1)
Employer branding (2)
Employer resources (11)
Events (14060)
Executive appointments (150)
FDA (3633)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (227)
Gene editing (8)
Generative AI (10)
Gene therapy (25)
GLP-1 (51)
Government (628)
Guidances (63)
Healthcare (2917)
HIV (9)
IgA nephropathy (3)
Immunology and inflammation (7)
Immuno-oncology (4)
Indications (7)
Infectious disease (528)
Inflammatory bowel disease (14)
Influenza (21)
Intellectual property (26)
Interviews (12)
IPO (1810)
IRA (2)
Job creations (401)
Job search strategy (95)
JPM (2)
Kidney cancer (6)
Labor market (3)
Layoffs (24)
Leadership (1)
Legal (537)
Liver cancer (14)
Longevity (2)
Lung cancer (105)
Lymphoma (59)
Machine learning (7)
Management (3)
Manufacturing (98)
MASH (18)
Medical device (2525)
Medtech (2537)
Mergers & acquisitions (3622)
Metabolic disorders (74)
Multiple sclerosis (41)
NASH (3)
Neurodegenerative disease (48)
Neuropsychiatric disorders (4)
Neuroscience (511)
NextGen: Class of 2026 (704)
Non-profit (554)
Now hiring (3)
Obesity (21)
Opinion (18)
Ovarian cancer (30)
Pain (10)
Pancreatic cancer (32)
Parkinson's disease (28)
Partnered (3)
Patents (49)
Patient recruitment (39)
Peanut (4)
People (9206)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase 1 (1306)
Phase 2 (1827)
Phase 3 (1706)
Pipeline (647)
Policy (4)
Postmarket research (212)
Preclinical (602)
Press Release (11)
Prostate cancer (76)
Psychedelics (1)
Radiopharmaceuticals (131)
Rare diseases (57)
Real estate (868)
Recruiting (5)
Regulatory (3255)
Reports (10)
Research institute (437)
Resumes & cover letters (15)
Rett syndrome (4)
RSV (2)
Schizophrenia (3)
Series A (29)
Series B (23)
Service/supplier (1)
Sickle cell disease (1)
Spinal muscular atrophy (10)
Sponsored (7)
Startups (625)
Stomach cancer (2)
Supply chain (8)
The Weekly (1)
Vaccines (53)
Venture capital (12)
Weight loss (8)
Women's health (23)
Date
Last 7 days (86)
Last 30 days (298)
Last 365 days (3857)
2026 (368)
2025 (4062)
2024 (5117)
2023 (6128)
2022 (10210)
2021 (9620)
2020 (8993)
2019 (6150)
2018 (4856)
2017 (5400)
2016 (5394)
2015 (6109)
2014 (4629)
2013 (4128)
2012 (4434)
2011 (4629)
2010 (4079)
Location
Africa (134)
Alabama (7)
Alaska (1)
Arizona (75)
Arkansas (2)
Asia (5453)
Australia (1307)
California (1345)
Canada (391)
China (61)
Colorado (110)
Connecticut (80)
Delaware (12)
Europe (15671)
Florida (204)
Georgia (65)
Idaho (4)
Illinois (170)
India (14)
Indiana (64)
Iowa (7)
Japan (49)
Kansas (14)
Kentucky (9)
Louisiana (5)
Maine (22)
Maryland (158)
Massachusetts (712)
Michigan (96)
Minnesota (103)
Mississippi (1)
Missouri (44)
Montana (6)
Nebraska (8)
Nevada (5)
New Hampshire (22)
New Jersey (267)
New Mexico (17)
New York (459)
North Carolina (249)
North Dakota (7)
Northern California (652)
Ohio (49)
Oklahoma (5)
Oregon (10)
Pennsylvania (130)
Rhode Island (7)
South America (156)
South Carolina (9)
Southern California (522)
Tennessee (59)
Texas (381)
United States (5270)
Utah (167)
Virginia (70)
Washington D.C. (9)
Washington State (131)
West Virginia (1)
Wisconsin (64)
Wyoming (2)
110,909 Results for "memed diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, announced expansion of their host immune response diagnostics partnership.
May 7, 2024
·
5 min read
Press Releases
MeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR
January 9, 2025
·
3 min read
Business
MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman and Peter Scheu as President of MeMed US
MeMed announces the appointment of Mr. Ori Hadomi as Chairman of the Board of Directors and Mr. Peter Scheu, as President of MeMed US.
November 6, 2023
·
2 min read
Press Releases
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology
Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic Capabilities
January 15, 2026
·
4 min read
Press Releases
FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis
December 10, 2024
·
3 min read
Policy
MeMed awarded US BARDA contract to demonstrate clinical utility of the FDA-cleared MeMed BV® test for distinguishing bacterial from viral infections
MeMed is pleased to announce that it has been awarded a contract valued at $727,799 by the Division of Research, Innovation, and Ventures of the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority.
October 24, 2023
·
2 min read
FDA
MeMed: FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result And Broader Patient Access When Distinguishing Bacterial From Viral Infections
MeMed, a leader in the emerging field of advanced host response technologies, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for use of the MeMed BV® test on whole blood samples on the point-of-need MeMed Key® analyzer to help healthcare providers distinguish between bacterial and viral infections in 15 minutes.
July 19, 2023
·
2 min read
Press Releases
MASHNET Announces Founding of MASLD Diagnostic Coalition
February 4, 2026
·
4 min read
Press Releases
Cleveland Diagnostics Names Jack Kenny as Chairman of the Board
February 5, 2026
·
2 min read
Business
Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections
Beckman Coulter Diagnostics announced today a strategic partnership to jointly develop and commercialize the proven MeMed BV® test, a host immune response diagnostic that is able to distinguish between bacterial and viral infections for use on the Access Family of Immunoassay Analyzers.
January 31, 2023
·
5 min read
1 of 11,091
Next